F Mueller
Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study
Mueller F, Büchel B, Köberle D, Schürch S, Pfister B, Krähenbühl S, Froehlich T, Largiader C, Joerger M. Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study. Cancer Chemother Pharmacol 2012; 71:361-70.
09.11.2012Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study
09.11.2012Cancer Chemother Pharmacol 2012; 71:361-70
Mueller F, Büchel B, Köberle D, Schürch S, Pfister B, Krähenbühl St, Froehlich T K, Largiader C R, Joerger M
Outcome of intravenous thrombolysis in stroke patients weighing over 100 kg
Sarikaya H, Georgiadis D, Ballinari P, Mueller F, Siebel P, Weder B, Odier C, Michel P, Mattle H, Lyrer P, Engelter S, Arnold M, Baumgartner R. Outcome of intravenous thrombolysis in stroke patients weighing over 100 kg. Cerebrovasc Dis 2011; 32:201-6.
04.08.2011Outcome of intravenous thrombolysis in stroke patients weighing over 100 kg
04.08.2011Cerebrovasc Dis 2011; 32:201-6
Sarikaya H, Georgiadis D, Ballinari P, Mueller F, Siebel Philip, Weder B, Odier C, Michel P, Mattle H P, Lyrer P A, Engelter S T, Arnold M, Baumgartner R W